|
Time |
|
|
9-30 – 10-00 |
Registration. Welcome coffee/tea |
|
10-00 – 10-10 |
Opening address
Yu.V. Remnev, TEMPO Deputy Director |
|
10-10 - 10-25 |
Venture investment
Eu. Zaitsev, member of American Business Association of Russian Professionals AmBAR, Head of Asset Management Company, California, USA |
|
10-25 - 10-40 |
Regulatory development and its role in Due Diligence
Z. Pitkin, Vice President, Regulatory Affairs and Quality Systems, USA |
|
10-40 - 10-55 |
Organization of production of the NEITROSTIM preparation on the basis of human recombinant granulocyte colony-stimulating factor for the hemopoiesis correction
State Research Center of Virology & Biotechnology VECTOR |
|
10-55 – 11-10 |
Development of anticancer adenovirus preparation “CANCEROLYSIN” State Research Center of Virology & Biotechnology VECTOR |
|
11-10 – 11-25 |
Development of new preparation on a basis of recombinant receptor antagonist of interleukin-1 (ARIL) for treatment of inflammatory, autoimmune, and allergic diseases with aerosol delivery method
State Research Institute of Highly Pure Biopreparations, St.Petersburg |
|
11-25 – 11-40 |
Larviol ™ - Microbiological preparation against larvae of bloodsucking mosquitoes
Open Joint Stock Company “Institute of Applied Biochemistry and Machine Building ”Biochimmash” |
|
11-40 – 11-55 |
DEVELOPMENT OF BIOTECHNOLOGY FOR THE PRODUCTION OF ANTI-CANCER PREPARATION PACLITAXEL
Open Joint Stock Company “Institute of Applied Biochemistry and Machine Building ”Biochimmash” |
|
11-55 – 12-10 |
Organization of pilot production of a selective adsorbent
for atherosclerosis treatment
State Research Institute of Highly Pure Biopreparations, St.Petersburg |
|
12-10 – 12-25 |
Nanotechnology of immuneactive antimicrobial compositions
State Research Institute of Highly Pure Biopreparations, St.Petersburg |
|
12-25 – 12-40 |
THE COMBINED WOUND HEALING DRESSINGS
WITH THE PROPERTIES OF THE ARTIFICIAL SKIN
State Research Institute of Highly Pure Biopreparations, St.Petersburg |
|
12-40 – 12-55 |
PRODUCTION OF ANTI-SEPTIC PREPARATION “MIRASEPTÒ” Open Joint Stock Company “Institute of Applied Biochemistry and Machine Building ”Biochimmash” |
|
13-00 – 14-00 |
Lunch |
|
14-00 – 14-15 |
Stentless Aortic Valve Bioprostheses
Pavlov State Medical University of Saint-Petersburg |
|
14-15 – 14-30 |
Expression of human interferons beta and gamma in the milk of transgenic animals
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS |
|
14-30 – 14-45 |
Multi-epitope recombinant virus-like particle based vaccine for the prophylaxis and treatment of cow milk allergy
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS |
|
14-45 – 15-00 |
Collagenase-derived fragments of collagen for ulcer treatment
Imtek Ltd./Russian Cardiology Research Center |
|
15-00 – 15-15 |
Microbicidal gel for prophylaxis and therapy HIV/AIDS and other sexually - transmitted infections (STI) and development of technology of its manufacture
Medical-Biotechnological Center “Vector-T” Ltd.
|
|
15-15 – 15-30 |
GMP manufacture of synthetic peptide drugs
State Research Institute of Highly Pure Biopreparations, St.Petersburg |
|
15-30 – 15-45 |
Development of live trivalent culture influenza vaccine
State Research Center of Virology & Biotechnology VECTOR |
|
15-45 – 16-00 |
Coffee break |
|
16-00 – 16-15 |
Novel synthetic peptide immunomodulators
State Research Institute of Highly Pure Biopreparations, St.Petersburg |
|
16-15 – 16-30 |
Development of a new method for chronic viral hepatitis C immunotherapy using human recombinant interleukin-1 beta
State Research Institute of Highly Pure Biopreparations, St.Petersburg |
|
16-30 – 16-45 |
The establishing of TB-test collection production for speeded up identification of the Mycobacterium tuberculosis antibiotic resistance
State Research Center of Applied Microbiology & Biotechnology, Obolensk |
|
16-45 – 17-00 |
Concluding remarks
Yu.V. Remnev, TEMPO Deputy Director |